Aprea Therapeutics (APRE) EPS (Basic) (2022 - 2026)
Aprea Therapeutics (APRE) posted quarterly EPS (Basic) of -$0.23 for Q1 2026, up 65.73% year-over-year from -$0.14 in Q1 2025, and up 97.41% quarter-over-quarter from -$9.02 in Q4 2025.
Aprea Therapeutics (APRE) EPS (Basic) (2022 - 2026) Analysis & Trends
Aprea Therapeutics (APRE) has reported EPS (Basic) for 5 consecutive years, with -$0.23 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 65.73% year-over-year to -$0.23; the TTM figure through Mar 2026 stood at -$4.69 (up 57.0% YoY), while the FY2025 annual figure was -$10.64, up 9.07% from the prior year.
- EPS (Basic) grew to -$0.23 in Q1 2026 per APRE's latest filing, from -$9.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.23 in Q1 2026 and bottomed at -$86.96 in Q2 2022.
- Historically, EPS (Basic) has averaged -$8.24 across 5 years, with a median of -$0.96 in 2023.
- On a YoY basis, EPS (Basic) climbed as much as 98.87% in 2023 and fell as far as 774.09% in 2023.
- Aprea Therapeutics' EPS (Basic) stood at -$1.68 in 2022, then tumbled by 774.09% to -$14.68 in 2023, then jumped by 34.01% to -$9.69 in 2024, then climbed by 6.89% to -$9.02 in 2025, then soared by 97.41% to -$0.23 in 2026.
- Business Quant data shows APRE's EPS (Basic) at -$0.23 in Q1 2026, -$9.02 in Q4 2025, and -$0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Aprea Therapeutics | 34.25 Mn | 34.25 Mn | - | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.27 |
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -9.02 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.56 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -9.69 |
| Sep 30, 2024 | -0.69 |
| Jun 30, 2024 | -0.65 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -14.68 |
| Sep 30, 2023 | -0.94 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -1.42 |
| Dec 31, 2022 | -1.68 |
| Sep 30, 2022 | -2.42 |
| Jun 30, 2022 | -86.96 |